TherapeuticsMD, Inc.
TXMD
$1.15
$0.010.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.76M | 1.60M | 996.00K | 1.20M | 1.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.76M | 1.60M | 996.00K | 1.20M | 1.30M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.76M | 1.60M | 996.00K | 1.20M | 1.30M |
| SG&A Expenses | 4.74M | 5.34M | 5.62M | 7.17M | 8.90M |
| Depreciation & Amortization | 509.00K | 1.05M | 1.08M | 1.03M | 922.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.25M | 6.39M | 6.70M | 8.20M | 9.83M |
| Operating Income | -3.49M | -4.79M | -5.71M | -7.00M | -8.52M |
| Income Before Tax | -2.34M | -4.01M | -4.88M | -6.24M | -7.74M |
| Income Tax Expenses | -31.00K | -43.00K | -43.00K | -43.00K | -43.00K |
| Earnings from Continuing Operations | -2.31 | -3.97 | -4.83 | -6.20 | -7.70 |
| Earnings from Discontinued Operations | 131.00K | 651.00K | -1.25M | -1.21M | -2.58M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.18M | -3.32M | -6.09M | -7.41M | -10.28M |
| EBIT | -3.49M | -4.79M | -5.71M | -7.00M | -8.52M |
| EBITDA | -2.98M | -4.23M | -5.11M | -6.45M | -8.08M |
| EPS Basic | -0.19 | -0.29 | -0.55 | -0.70 | -1.00 |
| Normalized Basic EPS | -0.19 | -0.22 | -0.27 | -0.36 | -0.47 |
| EPS Diluted | -0.19 | -0.30 | -0.56 | -0.70 | -1.01 |
| Normalized Diluted EPS | -0.19 | -0.22 | -0.27 | -0.36 | -0.47 |
| Average Basic Shares Outstanding | 46.13M | 45.64M | 44.81M | 43.49M | 41.72M |
| Average Diluted Shares Outstanding | 46.13M | 45.64M | 44.81M | 43.49M | 41.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |